| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |